-
"Thank you for inviting me to this year's Antibody Therapeutic Xchange. As always, I really enjoyed exchanging ideas with the experts in the field. The in-person and virtual aspect of the Xchange were flawlessly executed. Kudos to the hubXchange team! I look forward to meeting to you at the next Xchange."
Group Leader Antibody Engineering, Alamar Biosciences
-
"Thank you again for yet another excellent meeting."
-
"It was a great event and really enjoyed it. It gave me a lot of new ideas and it was fantastic to talk with other pharma people about their struggles and insights which was very inspiring. The event was hybrid, it was perfectly fine and I think it is more important to have the right people present at these meetings, being virtual or physical does not really matter. I would very much like to participate next year as well if as I found it very valuable."
Director, Computational Drug Discovery, Novo Nordisk
-
"Excellent event to meet decision maker scientists of the AI drug discovery field from large or mid size pharma companies in the AI Drug Discovery space. I was able to extend my knowledge in where this field is going, and what to focus on in the future. The discussions were scientific but highly business related constantly considering opportunities to grow together but keep our IP separate and safe. Thanks again for everything."
Co-Founder & COO, Menten AI
-
"The event was a great opportunity to network and exchange ideas with colleagues. Participation was excellent, and the hybrid format helped to ensure that there was representation across biotech."
Senior Director. Clinical Development and Translational Medicine, Asceneuron
-
"It was definitely very nice and exciting. I'd like to join next year as well."
Director, Formulation and Product Development, NGM Bio
-
"Excellent meeting to interact with peers in the field. The organizers did a wonderful job to work with moderators to prepare a productive agenda. I also enjoyed learning and interacting directly with multiple businesses that support various AI, ML and data management and analysis for biotech companies. The Hybrid format was convenient especially as the moderators were actively engaging the virtual attendees."
Senior Director, TRex Bio
-
"It was a pleasure once again, really enjoyed the meeting and hope I can join again next year."
Chief Scientific Officer, Nkarta Therapeutics
-
"The sessions were great and I enjoyed them. Looking forward to the next inspirational Xchange! Thank you again for all your help and your ever tireless efforts in making this Xchange such a success."
Senior Director, Antibody Discovery & Engineering, TrueBinding
-
"The round table setting for the discussions was very helpful in keeping the meeting interactive and less lecture-like. The one-on-one meetings were also good and focused."
-
"Thank-you for organizing a great event. Please pass this message along to the rest of your team. The logistics were smooth, you kept us well-fed, and---most importantly---I forged valuable connections with local colleagues. There is a high probability that a couple of these new connections will open doors to new partnerships between our respective teams, which is an incredible outcome from a one-day event. Please invite me again!"
Head of Computational Biology, Verge Genomics
-
"It was great to reconnect with colleagues and talk about science in person for the first time in almost two years! I’m looking forward to participating again next year.”
"Co-Founder & Chief Executive Officer", Abalone Bio
-
"Thank you again for allowing me to be part of this meeting. I very much enjoyed it and I hope that the participants of my round table also took something positive away. I look forward to next year’s meeting."
Senior Vice President, Biology, RAPT Therapeutics
-
"It was indeed my honor and pleasure to be able to participate actively in this year’s I-O HubXchange. The ambience of the sessions was informal which encourages numerous enjoyable and constructive discussions with many knowledgeable/esteem individuals in the field. Thoroughly a positive experience."
Senior Director, Immuno-Oncology, Exelixis
-
"liked the format, size and the opportunity to lead a session. I met some interesting people and made some good contacts so all in all a success so I’m totally looking forward to next year!"
Director, Antibody Discovery, Xencor
-
"It was a positive experience indeed!"
Vice President, Biology Translational Development, Coherus Biosciences
-
"The meeting was well organized, and it was a great experience to interact with participants. Thank you and your colleagues for organizing the meeting."
Executive Director, Small Molecule & Oligonucleotide Process, Ultragenyx Pharmaceutical
-
"It was a great experience attending the Oligonucleotide Xchange event series. I led 2 discussion sessions and absolutely enjoyed it. It was great to meet with colleagues working in oligonucleotide therapeutics and discuss the latest development in the field. I am thankful to the organizers and the entire hubXchange team for their great planning and execution of such a successful event."
Associate Director, Head of Bioanalytics, Switch Therapeutics
-
"Crown Bioscience greatly values our relationship with the hub-Xchange team. The professionalism, responsiveness and the follow-through on the part of hubXchange directly led to some of most substantive conversations we’ve ever had at any similar networking-centric conferences. The facilitation of such quality face-to-face, mutually-beneficial conversations is unsurpassed by any other organization in the industry."
Senior Director and Head Western Region Business Development, Crown Bioscience
-
"hubXchange has been very good in bringing together people in a context where they can share the solutions they found to develop their innovative products. We will continue to work with hubXchange across all of their meetings for the foreseeable future because we get a good ROI from these meetings."
-
"The hubXchange meeting was outstanding. The organizers brought the right people and engaged them in a roundtable discussion on current challenges/issues on antibody engineering and immune-oncology areas. The topics were cutting edge and discussion was productive with great networking opportunities."
Vice President, R&D, OncoResponse Inc.
-
"Thanks for organizing this productive meeting. Always helpful to engage and connect with colleagues experiencing similar challenges in the field of IO and translational biomarkers."
Director, Translational Research & Biomarkers, Oncorus
-
"It was an absolute pleasure to be part of this fantastic forum. Please keep me in mind for the next one and any other events that you are planning. I am definitely planning to bring a few folks with me next time."
Head of Biologics, Dragonfly Therapeutics
-
"Congratulations on another excellent meeting. In addition to the roundtable discussions, I had some great 1:1 discussions with companies that are resulting in follow up talks. I would be honoured to be kept on your future meeting lists."
Associate Director, Translational Sciences, Takeda Oncology
-
"The most productive roundtable discussions that I’ve seen. Participants were candid and insightful, the groups were just the right size, and the topics were highly relevant."
Executive Director, Head of Biology, Mersana Therapeutics
-
"Thanks again for what was a great meeting. Excellent group of participants that were very engaged in the discussions and brought a lot of knowledge to the table. Already looking forward to next year."
Vice President R&D, Immunome
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)
)
)